Osteoclasts and Arthritis
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Inflammatory arthritis typically presents as joint pain, swelling, and stiffness, which may be of short duration. For example, parvovirus B 19 infection, attended by painful polyarticular swelling, generally resolves spontaneously within 2 wk without joint destruction. Chronic manifestations of these diseases, however, typically represent a self-perpetuating hyperimmune, pathological phenomenon and yield progressive structural damage. Rheumatoid (RA) and psoriatic arthritis, in particular, are joint destructive consequent to chronic inflammation of the synovial membrane and its bone-associated ligaments and tendons. The dominance of bone destruction in inflammatory arthritis is best documented in RA, a condition affecting roughly 1% of western society.1 It is characterized by painful, symmetrical swelling, particularly of small, peripheral joints. The disease is insidious, appearing at any age, with woman most frequently afflicted. Autoantibodies, such as rheumatoid factor and those recognizing citrullinated proteins, develop in most patients. The skeletal consequences of RA are usually evident by conventional radiography, manifesting as periarticular bone erosions and systemic osteoporosis, the latter a common component of virtually all forms of chronic inflammatory disease, including those that are extraskeletal.2, 3 The clinical importance of local bone erosions is underscored by their association with impaired joint function.4, 5 As bone damage accumulates in a rheumatoid joint, the likelihood of full functional restoration diminishes, even in the face of optimal therapy.6 Although these lesions are usually more pronounced with time, initial bone erosions emerge early after disease onset. By 6 mo, periarticular osteolysis is evident in approximately one half of RA patients7 and, in fact, erosions may appear within <12 wk.8 The rapid degradation of periarticular bone is achieved by osteoclasts, the unique skeletal resorptive cells derived from monocyte/macrophage precursors. The initial description of osteoclasts in the inflamed joint dates to the 19th century,9, 10 but the first detailed molecular characterization of these cells in RA patients was published by Gravallese et al. in the late 1990s.11 They showed that osteoclasts, as multinucleated cells expressing CD68, TRACP, cathepsin K, and the calcitonin receptor, appear at the interface of inflammatory synovial tissue and periosteal surface and eventually form resorption lacunae. Mononuclear macrophage-lineage cells, which are less differentiated but committed to the osteoclast phenotype, also migrate to inflamed joints, predominantly in the vicinity of, but not necessarily directly attached to, the bone surface. These observations establish that osteoclasts populate the chronically inflamed joint, in abundance, and are the product of local differentiation of their precursors. Osteoclasts also appear in the joints of patients with psoriatic arthritis, confirming these cells are a common component of multiple forms of chronic inflammatory joint disease.12 Joint anatomy likely dictates location of bone erosions. Such lesions, for example, usually localize where the synovial membrane inserts into the periosteal surface and at the edges of bones, which confine the joint space. This area is also close to the proximal rim of articular cartilage and the attachment sites of ligaments and tendon sheaths. These anatomical properties provide insight into the erosive mechanism because they indicate how inflamed synovial membrane, as well as that lining tendon sheaths, contact the bone surface.13 These features also explain why bone erosions typically occur at the radial sites of the metacarpophalangeal joints juxtaposed to tendons, collateral ligaments, and insertion sites of the synovial membrane.14 Animal models of arthritis also confirm that osteoclasts and erosions initially develop where inflamed tendon sheaths pass bony joint edges.15 The presence of osteoclasts within resorptive lacunae provides compelling circumstantial evidence these cell are responsible for structural damage attending inflammatory arthritis. This concept conflicts with the hypothesis that fibroblast-like synoviocytes have the capacity to directly degrade bone through metalloproteinase production.16 These activated mesenchymal cells do invade and destroy superficial, nonmineralized articular cartilage. However, experiments using arthritic osteopetrotic mice, in whom osteoclast formation or function is compromised, established that degradation of bone or mineralized cartilage is mediated by the bone-resorptive polykaryon. In fact, failure of osteoclasts to resorb cartilage is responsible for the pathognomonic histological feature of osteopetrosis, namely persistence of cartilaginous "bars" in metaphyseal bone.17, 18 Osteopetrotic animals protected from destruction of bone, but not of superficial cartilage, in face of severe joint inflammation include mice lacking the key osteoclastogenic
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass, D. A., Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.017 · Cited by 1,558
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440 · cited 2×
“This process, however, requires at least constitutive amounts of RANKL, which ‘‘primes’’ macrophages to commit to the osteoclast phenotype in response to TNF.(40) In a reciprocal fashion, TNF ‘‘primes’’ these precursors to undergo osteoclast differentiation in response to relatively small amounts of RANKL.”
BackgroundSelf-citationT-Cell mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ.
Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., et al. (2000) · Nature · doi:10.1038/35046102 · Cited by 1,358
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.
Pettit, A. R., Ji, H., von Stechow, D., Müller, R., Goldring, S. R., Choi, Y., Benoist, C., & Gravallese, E. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63016-7 · Cited by 807 · cited 1×
“the pathognomonic histological feature of osteopetrosis, namely persistence of cartilaginous ‘‘bars’’ in metaphyseal bone.((17,18)) Osteopetrotic animals protected from destruc-”
BackgroundOsteoclasts are essential for TNF-α-mediated joint destruction.
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215582 · Cited by 474
Self-citationOsteoprotegerin Reduces Osteoclast Numbers and Prevents Bone Erosion in Collagen-Induced Arthritis
Romas, E., Sims, N. A., Hards, D. K., Lindsay, M., Quinn, J. W. M., Ryan, P. F. J., Dunstan, C. R., Martin, T. J., & Gillespie, M. T. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64417-3 · Cited by 368
Redlich, K., Hayer, S., Maier, A., Dunstan, C. R., Tohidast‐Akrad, M., Lang, S., Türk, B., Pietschmann, P., Woloszczuk, W., Haralambous, S., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10097 · Cited by 285
Self-citationLi, P., Schwarz, E. M., O'Keefe, R. J., Ma, L., Boyce, B. F., & Xing, L. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301233 · Cited by 220
Cited by
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Self-citationInduction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
Harre, U., Georgess, D., Bang, H., Bozec, A., Axmann, R., Ossipova, E., Jakobsson, P.-J., Baum, W., Nimmerjahn, F., Szarka, E., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60975 · Cited by 736
Self-citationXu, F., & Teitelbaum, S. L. (2013) · Bone Research · doi:10.4248/br201301003 · Cited by 523
Self-citationEffects of inflammatory and anti‐inflammatory cytokines on the bone
Schett, G. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02545.x · Cited by 292
Self-citationZhao, B., Grimes, S. N., Li, S., Hu, X., & Ivashkiv, L. B. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111566 · Cited by 182
Metadata
- Authors
- Schett, G., & Teitelbaum, S. L.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07-01
- Volume
- 24
- Issue
- 7
- Pages
- 1142-1146
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2035685260
- Cited by
- 119
- References
- 11
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Osteoclasts and Arthritis. https://app.cochat.ai/papers/10.1359/jbmr.090533
- The paper
- Schett, G., & Teitelbaum, S. L. (2009). Osteoclasts and Arthritis. Journal of Bone and Mineral Research. https://doi.org/10.1359/jbmr.090533
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.